Visual and Anatomic Outcomes in Patients with Diabetic Macular Edema with Limited Initial Anatomic Response to Ranibizumab in RIDE and RISE
Open Access
- 1 June 2016
- journal article
- research article
- Published by Elsevier in Ophthalmology
- Vol. 123 (6) , 1345-1350
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Diabetic Macular Edema: Pathophysiology and Novel Therapeutic TargetsOphthalmology, 2015
- Long-term Effects of Therapy with Ranibizumab on Diabetic Retinopathy Severity and Baseline Risk Factors for Worsening RetinopathyOphthalmology, 2015
- Baseline Choroidal Thickness as a Predictor for Response to Anti–Vascular Endothelial Growth Factor Therapy in Diabetic Macular EdemaAmerican Journal of Ophthalmology, 2015
- Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edemaClinical Ophthalmology, 2014
- Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III TrialsOphthalmology, 2013
- Long-term Effects of Ranibizumab on Diabetic Retinopathy Severity and ProgressionArchives of Ophthalmology (1950), 2012
- Ranibizumab for Diabetic Macular EdemaOphthalmology, 2012
- The RESTORE StudyOphthalmology, 2011
- Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular EdemaOphthalmology, 2010
- Relationship between Optical Coherence Tomography–Measured Central Retinal Thickness and Visual Acuity in Diabetic Macular EdemaOphthalmology, 2007